GSK has licensed altSonflex1-2-3, its Shigella vaccine candidate, to Bharat Biotech for the continued development and ...

The label expansion for Moderna’s jab arrives at a juncture in America’s changing vaccine regulatory landscape.

Debiopharm has entered a co-research agreement with Alkyon Therapeutics to explore the potential of developing targeted RLTs.

The US Food and Drug Administration (FDA) has approved the label expansion of AbbVie’s Mavyret (glecaprevir/pibrentasvir).

The health secretary addressed NHS employees a day after the £29bn NHS funding was announced. A £29bn investment into the ...

The future of US immunisation is up in the air as outspoken critics of vaccines populate an integral recommendation committee ...

BioNTech has agreed to acquire CureVac for approximately $1.25bn, as the former amps up its strategy to offer cancer ...

GlobalData estimates that vutrisiran’s entrance into the ATTR-wt market will change the treatment paradigm.